Back to results
US 7,732,459 B2Granted
CCR1 antagonists and methods of use therefor
AssigneeMillennium Pharmaceuticals, Inc.
InventorsKenneth G. Carson, Geraldine C. B. Harriman, Shomir Ghosh
Life of this patent
Estimating the term…
Abstract
The invention provides compounds having the formula: wherein R1 is halogen. The invention also provides compositions comprising the compounds, and methods of treating diseases or disorders that comprise administering one or more of the compounds to a subject in need thereof. The disclosed compounds have CCR1 antagonist activity.
Claims12
A compound having the formula:
- or a physiologically acceptable salt thereof, wherein R1 is a halogen.
A compound having the structure:
- or a physiologically acceptable salt thereof, wherein R1 is a halogen.
A compound having the formula:
- or a physiologically acceptable salt thereof, wherein R1 is a halogen.
Dependencies are inferred from the claim text.